The Delivery of Thrombi-Specific Nanoparticles Incorporating Oligonucleotides into Injured Cerebrovascular Endothelium

Wei Shi,Heng Mei,Jun Deng,Chen,Huafang Wang,Tao Guo,Bo Zhang,Zhiqing Pang,Xinguo Jiang,Xuxia Wang,Hao Lei,Yu Hu

DOI: https://doi.org/10.1016/j.biomaterials.2013.02.013

IF: 14

2013-01-01

Biomaterials

Abstract:In acute vascular events, the endothelium derived tissue factor (TF) is the trigger of the coagulation cascade. In this study, EGFP-EGF1 protein-conjugated PEG-PLGA nanoparticle was employed as a TF targeting vehicle, the NF-κB decoy oligonucleotides (ODNs) was incorporated into it and the resulting EGF1-EGFP-NP-ODNs were evaluated as a vector for therapy of cortex infarction. At 2 h after transfection of TF expressed rat brain capillary endothelial cell, EGF1-EGFP-NP-ODNs was more efficiently internalized and located in the cytoplasm than NP-ODNs. At 4 h and 6 h after administration, ODNs were present in the nuclei and obviously inhibited the TF expression. At 6 h after i.v. administration in vivo, most EGF1-EGFP-NP were accumulated in the embolism vessels, distributed in the damaged endothelial cells and lowered the TF expression. At 24 h after i.v. administration, MR imaging of cortex infarcts were predominantly dwindled.